Homozygous alpha-synuclein p.A53V in familial Parkinson’s disease by Yoshino, Hiroyo, PhD, Hirano, Makito, MD, PhD, Stoessl, A. Jon, MD, Imamichi, Yoko, BS, Ikeda, Aya, MD, Li, Yuanzhe, MD, PhD, Funayama, Manabu, PhD, Yamada, Ikuko, MD, PhD, Nakamura, Yusaku, MD, PhD, Sossi, Vesna, PhD, Farrer, Matthew J., PhD, Nishioka, Kenya, MD, PhD, Hattori, Nobutaka, MD, PhD

Get full text

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I... by Marks, William J, MD, Ostrem, Jill L, MD, Verhagen, Leonard, MD, Starr, Philip A, MD, Larson, Paul S, MD, Bakay, Roy AE, MD, Taylor, Robin, MSN, Cahn-Weiner, Deborah A, PhD, Stoessl, A Jon, MD, Olanow, C Warren, MD, Bartus, Raymond T, PhD

Get full text

Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies by Wile, Daryl J, Dr, Agarwal, Pankaj A, DM, Schulzer, Michael, Prof, Mak, Edwin, BASc, Dinelle, Katherine, MSc, Shahinfard, Elham, PhD, Vafai, Nasim, MASc, Hasegawa, Kazuko, PhD, Zhang, Jing, Prof, McKenzie, Jessamyn, LPN, Neilson, Nicole, RN, Strongosky, Audrey, BA, Uitti, Ryan J, Prof, Guttman, Mark, MD, Zabetian, Cyrus P, MD, Ding, Yu-Shin, Prof, Adam, Mike, PhD, Aasly, Jan, Prof, Wszolek, Zbigniew K, Prof, Farrer, Matthew, Prof, Sossi, Vesna, Prof, Stoessl, A Jon, Prof

Get full text